Join us for a webinar exploring how LiquidHALLMARK®, a cutting-edge liquid biopsy test, is transforming cancer care.

Diagnostic advances allow earlier & more accurate detection of Alzheimer's using cerebrospinal fluid biomarkers.

Register now – Nov. 12, 2025 - PACE/State of FL - Review known genetic predisposing factors to acute or chronic pancreatitis, as well as define who may benefit from genetic testing.

When introducing a new initiative in the medical laboratory environment, effective change management is essential.

Reviewing the challenges healthcare providers face in distinguishing between new and residual marijuana use in patients.

Maintaining a diverse and sufficient blood supply is essential for hospital care, as transfusions support many critical treatments. Several known red blood cell antigens make donor-recipient matching complex, especially across diverse populations, highlighting the need to overcome barriers such as mistrust or lack of awareness in underrepresented communities. In the U.S., blood donors must meet specific health and eligibility requirements to ensure safety for both donor and recipient. The following podcast episodes feature blood banking-related interviews that discuss these topics.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and Div Dubey, M.B.B.S., a neurologist and co-director of the Clinical Neuroimmunology Laboratory at Mayo Clinic, explore the topic of peripheral neuropathy.

Joseph Yao, M.D., explains how Mayo Clinic Laboratories' new quantitative assay (Mayo ID: ADVQU) goes beyond qualitative testing to evaluate transplant patients for adenovirus infection. Adenovirus can cause life-threatening disease in immunocompromised transplant patients, especially children.

Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered due to the upcoming July 4th holiday. To ensure specimen stability and prevent delays, follow the guidelines outlined below for domestic clients and international clients.

Our annual Outreach Conference, Leveraging the Laboratory, will take place on Sept. 16–17, 2025, in Nashville. This year’s theme, “Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs. Here are the top 3 reasons why you should attend.

PACE/State of FL - The critical role of pharmacogenomics and therapeutic drug monitoring (TDM) in managing immunosuppressive therapy for solid organ transplant recipients.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, discuss global trends in diagnostic manufacturing and their implications for laboratory professionals.

Registration is now open for the 2025 Mayo Clinic Classical Hematology Conference: Nonmalignant Hematology and Bleeding and Thrombotic Disorders. Reserve your spot today.

In this microlearning, you'll discover practical tips and proven strategies for running virtual meetings that are both efficient and effective. You'll also review a few simple etiquette guidelines that you can follow to ensure a professional and productive meeting.

In this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, is joined by colleagues Ellen Dijkman Dulkes and Brianne Newton. They discuss common challenges outreach programs face that can lead to a program’s failure and how to overcome those barriers.